Abstract：Objective: To analyze and evaluate the clinical efficacy of propranolol and methimazole in the treatment of hyperthyroidism. Methods:80 patients with hyperthyroidism were selected from the fourth affiliated hospital of Harbin medical university.All patients were divided into control group and observation group by random number method, with 40 cases in each group.Patients in the control group were treated with thimidazole, and patients in the observation group were treated with thimidazole combined with the control group.The improvement of thyroid function index, clinical treatment effect and the incidence of adverse reactions after treatment were compared between the two groups. Results:Before treatment, there was no significant difference in thyroid function indicators between the two groups (P>0.05). After treatment, the improvement of thyroid function in the observation group was significantly better than that in the control group, with statistically significant differences (P<0.05). The effective rate of clinical treatment in the observation group was significantly higher than that in the control group (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: The combined use of propranolol and methimazole in the treatment of hyperthyroidism has a significant effect, which can effectively improve the clinical symptoms of patients without increasing the incidence of adverse reactions.
李响, 王松柏. 普萘洛尔和甲巯咪唑对甲状腺功能亢进的疗效评价[J]. 河北医学, 2019, 25(11): 1837-1839.
LI Xiang, WANG Songbai. Efficacy Evaluation of Propranolol and Methimazole in the Treatment of Hyperthyroidism. HeBei Med, 2019, 25(11): 1837-1839.
2019, Vol. 25 
冀公网安备13080202000677号